Related Experiment Video
Updated: Jun 23, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
[Molecular aspects of head and neck, and lung cancer oncogenesis]
Y Loriot1, P Mordant, P Fouret
1Département de Médecine, Institut Gustave-Roussy, 39 Rue Camille-Desmoulins, 94800 Villejuif Cedex, France.
Abstract:
Lung and head and neck cancers result from a multistep process involving activation of oncogenes and inactivation of tumor-suppressor genes. These two processes share common features and molecular players, while their corresponding clinical entities are both triggered by the tobacco carcinogens. In many cases, the molecular abnormalities associated with these multi-step and multi-focal processes can be found in pre-malignant lesions and normal tissue. The growing knowledge of the molecular basis of lung and head and neck carcinogenesis allows to better selecting molecular alterations that can be modulated by molecular targeted agents either in a curative or in a chemopreventive approach.
Insights
Lung and head and neck cancers arise from multistep genetic changes, influenced by tobacco carcinogens. Understanding these molecular alterations aids in developing targeted therapies for cancer prevention and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Carcinogenesis
Background:
- Lung and head and neck cancers develop through a multistep process involving oncogene activation and tumor suppressor gene inactivation.
- These cancers share common molecular pathways and are linked to tobacco carcinogen exposure.
- Molecular abnormalities characteristic of these cancers can be detected in pre-malignant lesions and normal tissues.
Purpose of the Study:
- To explore the shared molecular basis of lung and head and neck carcinogenesis.
- To identify molecular alterations that can be targeted for therapeutic intervention.
- To evaluate the potential for molecular targeted agents in curative and chemopreventive strategies.
Main Methods:
- Analysis of molecular abnormalities in cancer development.
- Comparison of molecular players in lung and head and neck carcinogenesis.
- Investigation of molecular alterations in pre-malignant and normal tissues.
Main Results:
- Identified common molecular features and players in lung and head and neck cancer development.
- Confirmed the role of tobacco carcinogens in initiating these multi-step processes.
- Demonstrated the presence of molecular alterations in pre-malignant and normal tissues, suggesting early events in carcinogenesis.
Conclusions:
- Knowledge of molecular carcinogenesis provides a basis for selecting targeted therapeutic strategies.
- Molecular targeted agents hold promise for both treating and preventing lung and head and neck cancers.
- Early detection of molecular alterations in pre-malignant lesions could inform targeted chemoprevention.
Related Concept Videos
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
